Press Releases
Calidi is at the forefront of the genetic medicine revolution in cancer and other indications
Read the Latest
Calidi Biotherapeutics Announces Partnership with GenScript ProBio for Distribution of its SuperNova-1 Technology
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces European Patent Granted by EPO: Combination Immunotherapy Approach for Treatment of Cancer
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces FDA Approval for COVID-19 Treatment Manufactured by Partner, Personalized Stem Cells
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces Appointment of Jim Schoeneck, Accomplished Biotech Executive, to Board of Directors
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces Two Abstracts Accepted for Presentation at AACR 2020 Virtual Annual Meeting II
SAN DIEGO, CA – (BUSINESS WIRE) – Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi’s Contribution To The Treatment Of COVID-19
In A Short Time, The Novel Coronavirus Disease (COVID-19) Has Destructively Impacted Both The People…